Attana at PEGS 2010- the essential protein engineering summit

Tid 17 Maj 2010 – 21 Maj 2010

Plats Sheraton Boston Hotel, Boston Massachusetts

Staffan Grenklo Ph.D, Cell Biologist, Attana AB Presentation focus: In today’s quest for new therapeutic drugs, it is increasingly important to obtain early and informative data on potential agents in order to save time and costs. Combining biosensor technologies contributing to detailed information on molecular interactions with an experimental approach, as close as possible to the natural environment of action, increases the chances of selecting the optimal candidate already in the pre-clinical phase. Track: Pre-clinical/ clinical development of Antibodies, Wed May 19th http://www.pegsummit.com/

Kategorier

  • attana cell 200
  • attana
  • biosensor
  • biosensors
  • attana a200
  • qcm
  • pegs 2010

Kontakter

  • Attana 200- fast and straightforward analysis and the ability to run samples in 100% serum
    Licens:
    Medieanvändning
    Ladda ner
  • Attana Cell 200 biosensor- Label free, real time kinetics on cells
    Licens:
    Medieanvändning
    Ladda ner
  • Revolutionerande svensk uppfinning med potential att effektivisera läkemedelsutvecklingen
    Licens:
    Medieanvändning
    Filformat:
    .pdf
    Ladda ner
  • Crude Sample Analysis Made Easy
    Licens:
    Medieanvändning
    Filformat:
    .pdf
    Ladda ner

Relaterat innehåll

  • Attana AB launches new software suite

    Attana is proud to announce the release of Attaché 2.0, a powerful new software suite developed in collaboration with Ridgeview Instruments AB.

  • Attana's core business!

    View article in Innovations in Pharmaceutical Technology (IPT), a brief overview of Attana's core business. http://www.iptonline.com/viewinn.asp?cat=2&article=285